Integral Health Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Integral Health Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300,000	Closed	-$558K	–	74
2022 Q2	$558K	Buy	+300,000	New	+$572K	0.11%	63
2022 Q1	–	Sell	-200,000	Closed	-$788K	–	82
2021 Q4	$788K	Sell	200,000 -150,000	-43%	-$729K	0.22%	66
2021 Q3	$1.68M	Buy	+350,000	New	+$1.44M	0.48%	57
2021 Q1	–	Sell	-300,000	Closed	-$1.03M	–	84
2020 Q4	$1.03M	Buy	+300,000	New	+$572K	0.31%	56

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Integral Health Asset Management's LXRX Position: Q3 2022 in Review

Integral Health Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2022, closing a stake of 300,000 shares — an estimated $558K sold.

Integral Health Asset Management first reported a position in LXRX in Q4 2020 and held it in 4 quarters. The position peaked at $1.68M in Q3 2021. 98 funds tracked by Wall St. Rank hold LXRX as of Q3 2022.

Integral Health Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Integral Health Asset Management sold 300,000 Lexicon Pharmaceuticals shares in Q3 2022, an estimated $558K.
Integral Health Asset Management first reported a position in Lexicon Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Integral Health Asset Management's Lexicon Pharmaceuticals position peaked at $1.68M in Q3 2021.
98 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2022.

Based on Integral Health Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.